Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New collaborative research from the Mommersteeg Group and MRC WIMM researchers shows that a protein called Runx1 plays a significant role in the formation of the cardiac scar that forms after the heart is injured, a scar that is known to inhibit heart regeneration. In the zebrafish, a freshwater fish known to be able to fully regenerate its heart after damage, they show that the absence of Runx1 results in enhanced regeneration. This indicates a potential new therapeutic target for heart repair.

One of the major obstacles in heart regeneration is the formation of a fibrotic scar. This scar is thought to result from the deposition of collagen and fibrin by epicardial myofibroblasts after a heart attack. Preventing scarring therefore has significant therapeutic potential.

Associate Professor Mathilda Mommersteeg and her team, in collaboration with Jana Koth and Roger Patient from the MRC Weatherall Institute of Molecular Medicine (Radcliffe Department of Medicine), are investigating the role of transcription factor Runx1 during zebrafish heart regeneration.

Runx1 is a transcription factor that plays a key role in determining the proliferative and differential state of multiple cell-types, during both development and adulthood. The Mommersteeg Group first identified Runx1 through their research into the role of a gene called lrrc10 in the Mexican cavefish, a fish that, like the zebrafish, demonstrates an ability to repair its heart after damage .

Following this initial identification, the team and their collaborators looked into the gene in more detail. Using fluorescent transgenic reporters and single-cell sequencing, they have shown that runx1 becomes widely expressed in the heart after injury, specifically in populations of endocardial cells and thrombocytes. These populations express genes associated with scarring such as fibrin and collagen and smooth muscle genes that suggest an identity similar to myofibroblasts; the cells implicated in directly forming the cardiac scar after injury.

In runx1 mutant zebrafish, however, these subsets of endocardial cells and thrombocytes are absent, and the wounds contain less collagen and fibrin, which indicates that these cells might contribute to collagen deposition instead of epicardium-derived myofibroblasts. The researchers show that runx1 mutant animals also have increased myocardial cell survival and proliferation following heart injury, and increased expression of fibrin degradation (fibrinolysis) genes through upregulation of the plasminogen receptor Annexin 2A. Conversely, wild type fish strongly upregulate serpine1 upon injury, which inhibits fibrinolysis.

This research demonstrates that Runx1 negatively regulates regenerative responses in the heart, providing a new therapeutic target for heart regeneration.

What we found so interesting was that zebrafish, that have a natural ability to regenerate their hearts after injury, are not even doing this optimally. Absence of Runx1 further speeds up regeneration in these fish. This finding can help us understand what mechanisms improve heart regeneration and, in the future, apply this to patients after a heart attack to improve heart repair. We now first need to further find out what exactly Runx1 is doing during heart regeneration, but drugs that block Runx1 are already being tested in patients with leukaemia, making it a very promising target for treatment. - Prof Mommersteeg

The full paper ‘Runx1 promotes scar deposition and inhibits myocardial proliferation and survival during zebrafish heart regeneration can be read in Development.

Credit to Development for their Research Highlight outlined in this article.

The DPAG team who have contributed to this paper include William Stockdale, Helen Potts and Professor Paul Riley.

Image Legend (above right): Adult regenerating zebrafish heart recreated with cell clusters from single cell sequencing data of runx1 mutant and wild-type hearts.

 

Similar stories

Joaquim Vieira recognised in national image competition

DPAG BHF Intermediate Research Fellow Dr Joaquim Vieira has been shortlisted for the British Heart Foundation’s annual ‘Reflections of Research’ image competition.

BHF Senior Fellowship renewal for Duncan Sparrow could pave the way to revealing unknown causes of heart defects in babies

Congratulations are in order for Associate Professor Duncan Sparrow, who has been awarded a renewal of his British Heart Foundation Senior Basic Science Research Fellowship. The award will fund crucial investigations into little understood environmental risk factors of congenital heart disease, and could one day lead to new therapeutic strategies.

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.